The investment is set to expand two facilities on US soil and is part of an overarching $50 billion commitment ...

The facility is designed the ease advanced therapy development and manufacturing for partners by offering closer ...

N-1 perfusion with XCell® ATF Systems increases upstream productivity and yields while using existing bioreactor ...

The Cincinnati Children’s Center has expanded its capacity to manufacture cellular products for rare diseases.

Industry leaders reveal how process intensification is transforming biomanufacturing with dramatic gains in yield, cost ...

Discover how AI, machine learning, and multispecific designs are transforming antibody engineering, reducing development ...

We spoke to the facility’s director about the state of CGTs and how the industry can rebuild confidence in advanced ...